|
|
Article: Phase Forward Reports Third Quarter 2009 Results.(Company overview)(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced its financial results for the third quarter of 2009 (see also Phase Forward Incorporated).
GAAP revenues for the third quarter of 2009 were $53.1 million, a 24% increase from $43.0 million in the third quarter of 2008. Within total revenues, electronic data capture (EDC) license, application hosting and other related revenues were $38.5 million, representing 71% of third quarter total non-GAAP revenues and an increase of 18% from $32.7 million in the prior year period.
Bob Weiler, chairman and chief executive officer, ...